WASHINGTON, DC – ABC2 (Accelerate Brain Cancer Cure), the leading venture-philanthropy organization dedicated to brain tumor research in the United States, announced the appointment of Keith Lampman-Perlman as Senior Vice President, Legacy and Major Gifts Officer.
ABC2’s CEO Max Wallace said the appointment reflected the efforts the organization is making to increase major gifts to support next-generation immunotherapy research, adaptive clinical trial development and a new molecular profiling project, Allele -- a first-of-its-kind project that brings robust genomic profiling to brain cancer patients.
“We have always admired and respected the work that Keith has done on behalf of the brain tumor community,” Wallace said. “Keith’s fundraising expertise is key to scaling our research projects to help as many patients as possible.” To that end, Lampman-Perlman said, “No career gave me the satisfaction and great sense of ‘purpose beyond self,’ than that of my prior work on behalf of the brain tumor community. When Max inquired about my interest in the position, I felt it was a calling I could not refuse and am excited to join the dynamic, research-driven, ABC2 team.”
Lampman-Perlman brings a broad base of experience to ABC2, combining community banking, major gift development, and nonprofit leadership experience. During his career, he has raised tens of millions of dollars for leading and national nonprofit institutions.
Prior to joining ABC², Lampman-Perlman most recently served as Interim Vice President of Philanthropy at United Methodist Homes of New Jersey, through his position as Vice President at Alford Executive Search. Over his career, Lampman-Perlman has also served as Executive Vice President of Catskill Savings Bank and Executive Director of the Macula Vision Research Foundation, and has held senior leadership positions with diverse organizations, including: Catholic Partnership Schools, National Brain Tumor Society, and Columbia Memorial Hospital Foundation.
Lampman-Perlman has a B.S. in Business Administration, with a concentration in finance, corporate, and securities law from The College of Saint Rose, Albany, New York.
About ABC2 (Accelerate Brain Cancer Cure)
ABC² is focused on speeding the discovery of a cure for brain cancer. By applying an aggressive, venture funding approach not typically seen in the nonprofit sector, ABC² closes the current gaps in funding in order to catalyze research and rapidly bring new therapies to patients. ABC² has awarded more than 100 grants totaling $20 million in brain tumor research funding to highly qualified investigators and physician-scientists from 54 institutions and companies. To learn more, visit www.abc2.org.